Argument: Gene patents impair rapid study of spreading diseases
Michael Crichton. "Patenting Life." New York Times (Op-Ed). February 13, 2007: "The plain truth is that gene patents aren’t benign and never will be. When SARS was spreading across the globe, medical researchers hesitated to study it — because of patent concerns. There is no clearer indication that gene patents block innovation, inhibit research and put us all at risk."